Jodantipyrin - first tabletted antivirial agent for treatment and prevention of tick-borne encephalitis and HFRS
Jodantipyrin - first tabletted antivirial agent for treatment and prevention of tick-borne encephalitis and HFRS
FAQ
Русский
   ::  Main  / For the specialist  / Influenza and other ARVIs  / Jodantipyrin effective agent for prophylaxis of influenza and other ARVIs. Information letter for doctors.

  • Influenza and other ARVIs
  • Jodantipyrin effective agent for prophylaxis of influenza and other ARVIs. Information letter for doctors.

  
 
 Энцефалит.ру -
все о клещевом
энцефалите,
клещевом боррелиозе
и других инфекциях
передаваемых
клещами.
 
Эксклюзивные товары
 
 
Medical and social-economic significance of the problem of respiratory viral infections can't be overestimated. Almost 90% of the population suffer from ARVI at least once a year, but some people do even more often. It predetermines a high disease incidence and even mortality rate on the whole.  Above all, influenza should be referred to the number of respiratory infections with the most sever course of the disease and serious consequences. Methods of influenza prophylaxis can be devided into 2 types: specific and non-specific prophylaxis.
Jodantipyrin preparation refers to agents of non-specific prophylaxis of viral infections.
 

Copyright (c) 2001 OOO NTM - science, technics, medicine - producer and supplier of the agent Power by Media-com